TG Therapeutics | Zinsaufwendungen Für Schuld

2022Q32023Q32024Q3

	Interest Expense On Debt	Veränderung		Datum
AbbVie	USD 610M		19M	2024-12
Alaunos Therapeutics	USD 0		0	2023-12
Amgen	USD 747M		29M	2024-12
Ardelyx	USD 3.97M		610K	2024-12
Arrowhead Research	USD 21.65M		7M	2024-12
Bayer	703M		61M	2024-12
Biogen	USD 60M		200K	2024-12
Corcept Therapeutics	6M		6M	2024-06
Dynavax Technologies	USD 1.7M		5K	2024-12
Gilead Sciences	USD 248M		10M	2024-12
J&J	USD 137M		56M	2024-12
Novartis	USD 275M		11M	2024-12
PTC Therapeutics	USD 42.11M		1.09M	2024-09
Regeneron Pharmaceuticals	USD 10.5M		3.3M	2024-12
Roche Holding	CHF 311.5M		1000K	2024-12
TG Therapeutics	USD 10.83M		6.86M	2024-09
Vertex Pharmaceuticals	USD 2.8M		4.7M	2024-12

TG Therapeutics Zinsaufwendungen Für Schuld - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2025.